Thailand approves China's Sinopharm COVID-19 vaccine
Thailand approved the Sinopharm coronavirus vaccine, making it the fifth after AstraZenaca, Sinovac, Johnson & Johnson and Moderna
Stay updated with breaking news from Siam Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Thailand approved the Sinopharm coronavirus vaccine, making it the fifth after AstraZenaca, Sinovac, Johnson & Johnson and Moderna
A royal academy chaired by Princess Chulabhorn, the youngest sibling of Thailand's king, on Friday said it would import 1 million doses of ...
It has been an exceptionally busy 24-36 hours for the regime’s virus “strategy.” Failures, turnarounds and a royal intervention point to a shemozzle. More significantly, they point to a royal/royalist failure and a rescue attempt. The media is reflecting a broader discontent as it refers to the aspects of the vaccine “rollout” as a “fiasco”…
The government must do a better job allaying fears about a shortage of vaccines while getting its act together before the mass vaccination rollout starts, supposedly next week. The situation is extremely confusing at present and the disarray will not make for an effective rollout.
Probably based on a royalist ideological position, the military-backed monarchists of Gen Prayuth Chan-ocha's government initially decided to put all of its vaccine eggs in just two baskets. One was the the Sino-Thai tycoon's Chinese vaccine. The other was the king's vaccine, where with state support a little known company, Siam Bioscience, owned by the…